KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Debt (2016 - 2025)

Historic Total Debt for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $54.6 billion.

  • Amgen's Total Debt fell 962.12% to $54.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $54.6 billion, marking a year-over-year decrease of 962.12%. This contributed to the annual value of $60.1 billion for FY2024, which is 698.62% down from last year.
  • According to the latest figures from Q3 2025, Amgen's Total Debt is $54.6 billion, which was down 962.12% from $56.2 billion recorded in Q2 2025.
  • Amgen's 5-year Total Debt high stood at $64.6 billion for Q4 2023, and its period low was $32.7 billion during Q1 2021.
  • For the 5-year period, Amgen's Total Debt averaged around $50.0 billion, with its median value being $56.2 billion (2025).
  • Its Total Debt has fluctuated over the past 5 years, first surged by 6851.21% in 2023, then crashed by 1037.02% in 2025.
  • Over the past 5 years, Amgen's Total Debt (Quarter) stood at $33.3 billion in 2021, then grew by 16.92% to $38.9 billion in 2022, then skyrocketed by 65.91% to $64.6 billion in 2023, then fell by 6.99% to $60.1 billion in 2024, then dropped by 9.17% to $54.6 billion in 2025.
  • Its Total Debt stands at $54.6 billion for Q3 2025, versus $56.2 billion for Q2 2025 and $57.4 billion for Q1 2025.